This study is testing a procedure called lymphovenous bypass (LVB) to see if it can prevent lymphedema (swelling caused by fluid buildup) in melanoma patients. LVB would be performed at the same time as surgery to remove lymph nodes (lymphadenectomy) in the armpit or groin. Researchers want to see if doing LVB during the initial surgery, rather than waiting for lymphedema to develop, can reduce its occurrence. They will also look at wound complications, how long drains are needed, and your quality of life. You may be able to join if you are 18 or older, have melanoma, and are having this type of lymph node surgery. The study aims to enroll 20 participants.

Study design

This is an interventional pilot study with a planned enrollment of 20 participants. It is a parallel cohort study, meaning participants will be assigned to different groups.

What's involved

Participants will undergo the lymphovenous bypass (LVB) procedure at the time of their lymph node surgery. Researchers will assess safety and side effects for about one year, and wound complications within 30 days.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for about one year to assess safety and adverse events, and for lymphedema occurrence at 3 months, 6 months, and 1 year after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.